medical disorders and a representative adult population", Eur Heart J, 23 (23), pp. 1867-1876.
71. Hoffmann U, Millea R, Enzweiler C, Ferencik M, et al, (2004), "Acute Myocardial Infarction: Contrast-enhanced Multi–Detector Row CT in a Porcine Model", Radiology, 231 (3), pp. 697-701.
72. Husmann L, Wiegand M, Valenta I, Gaemperli O, et al, (2008), "Diagnostic accuracy of myocardial perfusion imaging with single photon emission computed tomography and positron emission tomography: a comparison with coronary angiography", Int J Cardiovasc Imaging, 24 (5), pp. 511-518.
73. Huynh P K, Vu L C, Truong Q X, Nguyen C X, (2016), "Rest Thallium- 201/Stress Technetium-99m Sestamibi Dual-Isotope Myocardial Perfusion Single-Photon Emission Computed Tomography in Detecting of Chronic Coronary Artery Disease. Journal of Pharmacy and Pharmacology", Journal of Pharmacy and Pharmacology 4(5), pp. 183-191.
74. Iskander S, Iskandrian A E, (1998), "Risk assessment using single- photon emission computed tomographic technetium-99m sestamibi imaging", J Am Coll Cardiol, 32 (1), pp. 57-62.
75. James P A, Oparil S, Carter B L, Cushman W C, et al, (2014), "2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)", Jama, 311 (5), pp. 507-520.
76. Jessica L D, (2014), Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, pp. 1089-1154.
77. Kaandorp T A M, Lamb H J, van der Wall E E, de Roos A, et al, (2005), "Cardiovascular MR to access myocardial viability in chronic ischaemic LV dysfunction", Heart (British Cardiac Society), 91 (10), pp. 1359-1365.
78. Kalra D K, Zhu X, Ramchandani M K, Lawrie G, et al, (2002), "Increased myocardial gene expression of tumor necrosis factor-alpha and nitric oxide synthase-2: a potential mechanism for depressed myocardial function in hibernating myocardium in humans", Circulation, 105 (13), pp. 1537-1540.
Có thể bạn quan tâm!
- Giá Trị Của Spect-Ct Trong Xác Định Tính Sống Còn Của Vùng Cơ Tim Thiếu Máu Cục Bộ
- Đặc Điểm Lâm Sàng, Cận Lâm Sàng Của Nhóm Bệnh Nhân Có Sống Còn Cơ Tim Ở Vùng Thiếu Máu Trên Hình Ảnh Xạ Hình Tưới Máu Cơ Tim Bằng Kĩ Thuật Spect –
- Vai trò của xạ hình tưới máu cơ tim bằng kỹ thuật Spect-CT trong đánh giá tính sống còn cơ tim - 16
- Vai trò của xạ hình tưới máu cơ tim bằng kỹ thuật Spect-CT trong đánh giá tính sống còn cơ tim - 18
- Vai trò của xạ hình tưới máu cơ tim bằng kỹ thuật Spect-CT trong đánh giá tính sống còn cơ tim - 19
Xem toàn bộ 154 trang tài liệu này.
79. Katikireddy C K, Mann N, Brown D, Van Tosh A, et al, (2012), "Evaluation of myocardial ischemia and viability by noninvasive cardiac imaging", Expert Rev Cardiovasc Ther, 10 (1), pp. 55-73.
80. Kellman P, Xue H, Olivieri L J, Cross R R, et al, (2016), "Dark blood late enhancement imaging", Journal of Cardiovascular Magnetic Resonance, 18 (1), pp. 77.
81. Kim R J, Manning W J, (2004), "Viability Assessment by Delayed Enhancement Cardiovascular Magnetic Resonance", Circulation, 109 (21), pp. 2476-2479.
82. Kim R J, Wu E, Rafael A, Chen E-L, et al, (2000), "The Use of Contrast- Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction", New England Journal of Medicine, 343 (20), pp. 1445-1453.
83. Klocke F J, Baird M G, Lorell B H, Bateman T M, et al, (2003), "ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging)", Circulation, 108 (11), pp. 1404-1418.
84. Knuuti J, Wijns W, Saraste A, Capodanno D, et al, (2020), "2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes", Eur Heart J, 41 (3), pp. 407-477.
85. Lardo A C, Cordeiro M A, Silva C, Amado L C, et al, (2006), "Contrast- enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar", Circulation, 113 (3), pp. 394-404.
86. Lima R S, Watson D D, Goode A R, Siadaty M S, et al, (2003), "Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease", J Am Coll Cardiol, 42 (1), pp. 64-70.
87. Liu C J, Wu Y W, Ko K Y, Chen Y C, et al, (2015), "Incremental Diagnostic Performance of Combined Parameters in the Detection of Severe Coronary Artery Disease Using Exercise Gated Myocardial Perfusion Imaging", PLoS One, 10 (7), pp. e0134485.
88. Maron D J, Hochman J S, O'Brien S M, Reynolds H R, et al, (2018), "International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design", Am Heart J, 201 pp. 124-135.
89. Martí V, Ballester M, Udina C, Carrió I, et al, (1995), "Evaluation of Myocardial Cell Damage by In-111-Monoclonal Antimyosin Antibodies in Patients Under Chronic Tricyclic Antidepressant Drug Treatment", Circulation, 91 (6), pp. 1619-1623.
90. Masoudi F A, Ponirakis A, de Lemos J A, Jollis J G, et al, (2017), "Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries", J Am Coll Cardiol, 69 (11), pp. 1427-1450.
91. Metz L D, Beattie M, Hom R, Redberg R F, et al, (2007), "The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis", J Am Coll Cardiol, 49 (2), pp. 227-237.
92. Montalescot G, Sechtem U, Achenbach S, Andreotti F, et al, (2013), "2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology", European Heart Journal, 34 (38), pp. 2949-3003.
93. Moroi M, Yamashina A, Tsukamoto K, Nishimura T, (2012), "Coronary revascularization does not decrease cardiac events in patients with stable ischemic heart disease but might do in those who showed moderate to severe ischemia", Int J Cardiol, 158 (2), pp. 246-252.
94. Navare S M, Mather J F, Shaw L J, Fowler M S, et al, (2004), "Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis", J Nucl Cardiol, 11 (5), pp. 551-561.
95. Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, et al, (2018), "2018 ESC/EACTS Guidelines on myocardial revascularization", European Heart Journal, 40 (2), pp. 87-165.
96. Olmos L I, Dakik H, Gordon R, Dunn J K, et al, (1998), "Long-term prognostic value of exercise echocardiography compared with exercise 201Tl, ECG, and clinical variables in patients evaluated for coronary artery disease", Circulation, 98 (24), pp. 2679-2686.
97. Owlia M, Dodson J A, King J B, Derington C G, et al, (2019), "Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina", J Am Heart Assoc, 8 (15), pp. e012811.
98. Page B J, Banas M D, Suzuki G, Weil B R, et al, (2015), "Revascularization of chronic hibernating myocardium stimulates myocyte proliferation and partially reverses chronic adaptations to ischemia", J Am Coll Cardiol, 65 (7), pp. 684-697.
99. Panza J A, Holly T A, Asch F M, She L, et al, (2013), "Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction", J Am Coll Cardiol, 61 (18), pp. 1860-1870.
100. Perrone-Filardi P, Pace L, Prastaro M, Squame F, et al, (1996), "Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography", Circulation, 94 (11), pp. 2712-2719.
101. Ponikowski P, Voors A A, Anker S D, Bueno H, et al, (2016), "2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC", European Heart Journal, 37 (27), pp. 2129-2200.
102. Porter T R, Mulvagh S L, Abdelmoneim S S, Becher H, et al, (2018), "Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update", J Am Soc Echocardiogr, 31 (3), pp. 241-274.
103. Program N C E, (2002), "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel
III) final report", Circulation, 106 (25), pp. 3143-3421.
104. Ragosta M, Camarano G, Kaul S, Powers E R, et al, (1994), "Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography", Circulation, 89 (6), pp. 2562-2569.
105. Rahimtoola S H, (1989), "The hibernating myocardium", Am Heart J, 117 (1), pp. 211-221.
106. Reiner J S, Lundergan C F, Fung A, Coyne K, et al, (1996), "Evolution of Early TIMI 2 Flow After Thrombolysis for Acute Myocardial Infarction", Circulation, 94 (10), pp. 2441-2446.
107. Rinaldi C, Hall R, (2001), "Myocardial stunning and hibernation in clinical practice", International journal of clinical practice, 54 pp. 659- 664.
108. Romero J, Xue X, Gonzalez W, Garcia M J, (2012), "CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials", JACC Cardiovasc Imaging, 5 (5), pp. 494-508.
109. Sampson U K, Dorbala S, Limaye A, (2007), "Diagnostic Accuracy of Rubidium-82 Myocardial Perfusion Imaging with Hybrid Positron Emission Tomography/Computed Tomography in the Detection of Coronary Artery Disease", J Am Coll Cardiol, (49), pp. 1052-1058.
110. Santana C A, Folks R D, Garcia E V, Verdes L, et al, (2007), "Quantitative (82)Rb PET/CT: development and validation of myocardial perfusion database", J Nucl Med, 48 (7), pp. 1122-1128.
111. Shah D J, Kim H W, James O, Parker M, et al, (2013), "Prevalence of Regional Myocardial Thinning and Relationship With Myocardial Scarring in Patients With Coronary Artery Disease", JAMA, 309 (9), pp. 909-918.
112. Sharir T, Germano G, Waechter P B, Kavanagh P B, et al, (2000), "A new algorithm for the quantitation of myocardial perfusion SPECT. II: validation and diagnostic yield", J Nucl Med, 41 (4), pp. 720-727.
113. Sharir T, Hollander I, Hemo B, Tsamir J, et al, (2019), "Survival benefit of coronary revascularization after myocardial perfusion SPECT: The role of ischemia", J Nucl Cardiol, (11-Nov), pp. 14-21.
114. Shaw L J, Berman D S, Maron D J, Mancini G B, et al, (2008), "Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy", Circulation, 117 (10), pp. 1283- 1291.
115. Shaw L J, Cerqueira M D, Brooks M M, Althouse A D, et al, (2012), "Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial", J Nucl Cardiol, 19 (4), pp. 658-669.
116. Shaw L J, Iskandrian A E, (2004), "Prognostic value of gated myocardial perfusion SPECT", J Nucl Cardiol, 11 (2), pp. 171-185.
117. Simonetti O P, Kim R J, Fieno D S, Hillenbrand H B, et al, (2001), "An improved MR imaging technique for the visualization of myocardial infarction", Radiology, 218 (1), pp. 215-223.
118. Simonsen J A, Mickley H, Johansen A, Hess S, et al, (2017), "Outcome of revascularisation in stable coronary artery disease without ischaemia: a Danish registry-based follow-up study", BMJ Open, 7 (8), pp. e016169.
119. Stone G W, Hochman J S, Williams D O, Boden W E, et al, (2016), "Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise", J Am Coll Cardiol, 67 (1), pp. 81-99.
120. Sutherland K, (2010), "Bridging the quality gap : Heart failure.", The Heart Foundation, pp.
121. Tajouri T H, Chareonthaitawee P, (2010), "Myocardial viability imaging and revascularization in chronic ischemic left ventricular systolic dysfunction", Expert Rev Cardiovasc Ther, 8 (1), pp. 55-63.
122. Uebleis C, Hellweger S, Laubender R P, Becker A, et al, (2013), "The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction", Int J Cardiovasc Imaging, 29 (7), pp. 1645-1653.
123. van Heerde W L, de Groot P G, Reutelingsperger C P, (1995), "The complexity of the phospholipid binding protein Annexin V", Thromb Haemost, 73 (2), pp. 172-179.
124. Van Train K F, Areeda J, Garcia E V, Cooke C D, et al, (1993), "Quantitative same-day rest-stress technetium-99m-sestamibi SPECT: definition and validation of stress normal limits and criteria for abnormality", Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 34 (9), pp. 1494-1502.
125. Velazquez E J, Lee K L, Deja M A, Jain A, et al, (2011), "Coronary- Artery Bypass Surgery in Patients with Left Ventricular Dysfunction", New England Journal of Medicine, 364 (17), pp. 1607-1616.
126. Velazquez E J, Lee K L, Jones R H, Al-Khalidi H R, et al, (2016), "Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy", N Engl J Med, 374 (16), pp. 1511-1520.
127. Vlietstra R E, Frye R L, Kronmal R A, Sim D A, et al, (1980), "Risk factors and angiographic coronary artery disease: a report from the coronary artery surgery study (CASS)", Circulation, 62 (2), pp. 254- 261.
128. Wagner A, Mahrholdt H, Sechtem U, Kim R J, et al, (2003), "MR imaging of myocardial perfusion and viability", Magn Reson Imaging Clin N Am, 11 (1), pp. 49-66.
129. Waters D, Craven T E, Lesperance J, (1993), "Prognostic significance of progression of coronary atherosclerosis", Circulation, 87 (4), pp. 1067-1075.
130. Weinsaft J W, Klem I, Judd R M, (2007), "MRI for the Assessment of Myocardial Viability", Magnetic Resonance Imaging Clinics of North America, 15 (4), pp. 505-525.
131. Wellnhofer E, Olariu A, Klein C, Gräfe M, et al, (2004), "Magnetic Resonance Low-Dose Dobutamine Test Is Superior to Scar Quantification for the Prediction of Functional Recovery", Circulation, 109 (18), pp. 2172-2174.
132. WHO, (2004), "Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies", Lancet, 363 (9403), pp. 157-163.
133. Windecker S, Kolh P, Alfonso F, Collet J P, et al, (2014), "2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)", Eur Heart J, 35 (37), pp. 2541-2619.
134. Yancy Clyde W, Jessup M, Bozkurt B, Butler J, et al, (2013), "2013 ACCF/AHA Guideline for the Management of Heart Failure", Circulation, 128 (16), pp. e240-e327.
135. Brilakis, Emmanouil. Chapter 6 - Coronary angiography In: Brilakis E, Manual of Percutaneous Coronary Interventions. Academic Press, pp. 97-109
Phụ lục 1. PHIẾU THU THẬP DỮ LIỆU
Ngày thăm khám: …… / …… / 20……
Phần 1: Thông tin cá nhân
Mã số bệnh nhân: .......................................................................................
Họ và tên: ...................................................................................................
Ngày, tháng, năm sinh: ............................. ( tuổi)
Số điện thoại:...............................................................................................
Địa chỉ cư trú:..............................................................................................
Cân nặng: ...............kg. Chiều cao: ................. m. BMI: .................kg/m2
ữ
Giới tính:
Phần 2: Đặc điểm lâm sàng
Yếu tố nguy cơ:
Tăng huyết áp:
Có
Đái tháo đường:
Rối loạn lipid máu:
Hút thuốc lá:
Tiền căn gia đình có bệnh TM sớm:
NMCT cũ:
Bệnh thận mạn:
Triệu chứng lâm sàng:
Đau ngực kiểu mạch vành:
Đau ngực không điển hình:
-IV
Phân độ NYHA:
Phần 3: Kết quả cận lâm sàng